Seres Therapeutics (MCRB), a microbiome therapeutics platform company, has reported Q1 earnings results that fell below Street expectations. First quarter GAAP EPS of …
Seres Therapeutics Inc (NASDAQ:MCRB) are rising over 30%, as of this writing, after the drug maker announced plans to initiate a new SER-109 Phase …
